COMMUNIQUÉS West-GlobeNewswire

Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026
13/05/2026
Almost a third of adults taking Wegovy ® pill (oral semaglutide 25 mg) were early responders to treatment, achieving an average of 13.2% weight loss after four months and 21.6% weight loss at the end of the OASIS 4 [...]
Fortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicaments
13/05/2026
Le programme de subvention élargit l’accès aux technologies d’anticorps à domaine unique avancées, afin de soutenir la recherche et le développement des traitements de nouvelle génération BOSTON et LONDRES, 13 mai 2026 [...]
Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026
13/05/2026
Daix (France), New York City (New York, Etats-Unis), le 13 mai 2026 – Inventiva (Euronext Paris et NASDAQ: IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique au stade clinique spécialisée dans le [...]
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
13/05/2026
Total product sales of €30.5 million Cash position of €105.3 million as of end March 2026, excluding proceeds from successful reserved offering completed in April 2026 1 Program launched in April to further reduce [...]
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
13/05/2026
SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced [...]
Bavarian Nordic Announces Interim Results for the First Three Months of 2026
13/05/2026
COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2026. Revenue for the first three months was DKK 1, [...]
Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference
13/05/2026
WUHAN, China, May 13, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, participated in the 2026 National Medical Industry [...]
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
13/05/2026
SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy
13/05/2026
Proton therapy CBCT imaging solution across Proteus ® Portfolio providing clarity and confidence in IGPT Louvain-la-Neuve, Belgium, May 13, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle [...]
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
13/05/2026
ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, integrated biopharmaceutical company engaged in the discovery, development [...]
VisioCore Under Investigation: The Advanced Eyesight Vision Support Capsules with Organic Ingredients
13/05/2026
VisioCore Scam or Legit? Lutein, Zeaxanthin, and Bilberry Formula Ingredients, $59 Pricing, and 60-Day Guarantee Explained for 2026 Aurora, CO, May 12, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Bluesight Launches Prism, an AI Platform Built for Health Systems, Debuting with Prism Assistant
13/05/2026
Alexandria, VA, May 12, 2026 (GLOBE NEWSWIRE) -- Prism Assistant, the first product within Bluesight's new AI platform, is now available in ControlCheck and cuts time spent on drug diversion analysis by up to 97% [...]
Anteris Announces Results for the First Quarter of 2026
13/05/2026
MINNEAPOLIS and BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, [...]
Visi Flora Under Investigation: The Leading Gut-Eye Vitamins Formulation on the Market for Sharp Vision Support by VisiFlora
13/05/2026
VisiFlora Ingredients, Gut-Eye LPS Formula, Lutein, Saffron, Bilberry, Pricing, and 60-Day Guarantee Explained for 2026 Aurora, CO, May 12, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food [...]
GMR Solutions Inc. Announces Pricing of its Initial Public Offering
13/05/2026
LEWISVILLE, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- GMR Solutions Inc. (“GMR”) today announced the pricing of an initial public offering of 31,914,893 shares of its Class A common stock at $15.00 per share. Shares of [...]
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
12/05/2026
Initiated two late-stage clinical trials of LB-102: the pivotal Phase 3 NOVA-2 trial in schizophrenia and the Phase 2 ILLUMINATE-1 trial in bipolar depression Published results from the Phase 2 NOVA-1 trial of LB-102 in [...]
Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026
12/05/2026
INFORMATIONS RÉGLEMENTÉES Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026 Le lancement réussi de Genio aux États-Unis génère une croissance trimestrielle séquentielle de 25 % du chiffre [...]
TELA Bio Reports First Quarter 2026 Financial Results
12/05/2026
MALVERN, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial [...]
Nyxoah Reports First Quarter 2026 Financial and Operating Results
12/05/2026
REGULATED INFORMATION Nyxoah Reports First Quarter 2026 Financial and Operating Results Strong Genio launch in the U.S. drove 25% sequential quarterly U.S. revenue growth Continued clarity around HGNS and Genio [...]

Pages